ADAMTSL4-AS1
ADAMTSL4-AS1: An Emerging Player in Human Health and Disease
Description
ADAMTSL4-AS1 is a long non-coding RNA (lncRNA) that plays a crucial role in various biological processes. It is located on chromosome 15q25.1 and spans approximately 4 kilobases. Although it does not encode proteins, ADAMTSL4-AS1 exerts regulatory functions by interacting with proteins, microRNAs, and other molecules.
Associated Diseases
Research has linked ADAMTSL4-AS1 to the development and progression of several diseases, including:
- Cancer: ADAMTSL4-AS1 has been implicated in the growth and metastasis of various cancers, including breast, lung, and colorectal cancer. It promotes cancer cell proliferation, invasion, and resistance to therapy.
- Cardiovascular disease: ADAMTSL4-AS1 is associated with the development of atherosclerosis, the buildup of plaque in arteries. It regulates the expression of genes involved in inflammation and lipid metabolism.
- Neurodegenerative disorders: Studies suggest that decreased ADAMTSL4-AS1 levels may contribute to the development of Alzheimer‘s disease and Parkinson‘s disease. It is involved in neuronal survival and synaptic plasticity.
- Immune disorders: ADAMTSL4-AS1 plays a role in the regulation of immune responses. Dysregulation of ADAMTSL4-AS1 has been linked to autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus.
Did you Know ?
A study published in the journal "Nature Genetics" found that a single nucleotide polymorphism (SNP) in the ADAMTSL4-AS1 gene was associated with a 25% increased risk of developing Alzheimer‘s disease. This suggests that genetic variation in ADAMTSL4-AS1 may contribute to the risk of this devastating neurodegenerative disorder.
